Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Short communication: Activity of nisin, lipid bilayer fragments and cationic nisin-lipid nanoparticles against multidrug-resistant Staphylococcus spp. isolated from bovine mastitis

Full text
Castelani, L. [1, 2] ; Arcaro, J. R. P. [2] ; Braga, J. E. P. [2] ; Rosso, A. S. [2] ; Moura, Q. [1] ; Esposito, F. [3] ; Sauter, I. P. [4] ; Cortez, M. [4] ; Lincopan, N. [1, 3]
Total Authors: 9
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, BR-05508900 Sao Paulo - Brazil
[2] Dairy Cattle Ctr, Inst Anim Sci, BR-13380011 Nova Odessa, SP - Brazil
[3] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin Anal, BR-05508900 Sao Paulo - Brazil
[4] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508900 Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: JOURNAL OF DAIRY SCIENCE; v. 102, n. 1, p. 678-683, JAN 2019.
Web of Science Citations: 0

Staphylococci are the main etiological agents of bovine mastitis. Bacteriocins and nanoparticles have emerged as promising alternatives for the future development of antimicrobial agents. This study evaluated the activity of the bacteriocin nisin and bicelles of the synthetic cationic lipid dioctadecyldimethylammonium bromide, alone and in combination, against multidrug-resistant Staphylococcus spp. strains isolated from bovine mastitis. In summary, cationic nisin/dioctadecyldimethylammonium bromide nanoparticles are shown to be a promising alternative for the control of mastitis caused by multidrug-resistant Staphylococcus spp. (AU)

FAPESP's process: 16/08593-9 - Pan-Resistome of beta-lactamase (KPC-2, CTX-M-8, CTX-M-15)-producing Klebsiella pneumoniae and Escherichia coli isolates endemic in Brazil
Grantee:Nilton Erbet Lincopan Huenuman
Support Opportunities: Regular Research Grants
FAPESP's process: 13/04725-0 - Monitoring of multidrug-resistant Gram-negative bacteria of medical importance (human & veterinary): clinical/environmental impact and development of therapeutic alternatives and technology innovation products
Grantee:Nilton Erbet Lincopan Huenuman
Support Opportunities: Regular Research Grants
FAPESP's process: 13/15504-4 - Staphylococcus spp. multidrug-resistant isolated from bovine mastitis: alternative treatments based on the use of bacteriocins and cationic lipid nano-fragments
Grantee:Juliana Rodrigues Pozzi Arcaro
Support Opportunities: Regular Research Grants